Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

3rd China Vaccine Focus 2013

Published: Wednesday, April 10, 2013
Last Updated: Wednesday, April 10, 2013
Bookmark and Share
Events is now in its third time of providing a platform for technology exchange and new business development, new innovation release and is the region’s premier vaccine event in the Asia Pacific.

“China lays out its 12th Five-Year Plan for biopharma industry and the gross output value may reach 3 trillion RMB by 2015 with growth rate of 20% per year. And much importance has been attached to vaccine, mAb, gene engineering and protein engineering, peptides, blood products.”

With the Strong Support from ABO, Bayhelix, KoreaBio, SBIA, and etc, we are targeting towards 300 delegates, 40 exhibitors, and 40 speakers at 3rd China Vaccine Focus 2013 By the present of senior officials from Ministry of Health, PRC, SFDA/ FDA, NICPBP to address the latest regulatory issues on development of China vaccine industry. Through two days’ various sessions such as keynote presentations, interactive panel discussions, case studies, cocktail party and scheduled one-to-one business meetings, you will hear the latest breaking perspectives of both Chinese and MNC vaccine leaders. They will provide insights into their own company strategies for the coming years and how each perceives the marketplace developments. It will help you to win the vaccine market competition and strengthen your company’s dynamic growth in China’s vaccine market.

With nearly 1.4 bn people and approximately 17 million newborns each year, China has already been the largest producer and user of world vaccine products. Enhancing disease prevention awareness in adults, the spread of influenza A/H1N1 and other infectious diseases and Chinese government’s increased investment in epidemic prevention systems, recent improvements in China’s regulation, market, and technology scenario are all together creating an optimistic outlook for its vaccine industry. It is predicted that the vaccine sales revenue of China will increase to 20 billion RMB by 2015 with the growth rate of 10.8%.

CDMC events are devoted to delivering business intelligence by creating opportunities for knowledge sharing and business networking. CDMC endeavors to be the premier platform for acquiring business opportunities and strive to be part of your decision making. We firmly position ourselves as a landmark provider of B to B media service featuring China concept and high acclamation of customer. We pride ourselves in growing with your business and China's economy.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
ASMS 2016: Targeting Mass Spectrometry Tools for the Masses
The expanding application range of MS in life sciences, food, energy, and health sciences research was highlighted at this year's ASMS meeting in San Antonio, Texas.
Proteins in Blood of Heart Disease Patients May Predict Adverse Events
Nine-protein test shown superior to conventional assessments of risk.
Self-Assembling Protein Shell for Drug Delivery
Made-to-order nano-cages open possibilities of shipping cargo into living cells or fashioning small chemical reactors.
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Nanoprobe Enables Measurement of Protein Dynamics in Living Cells
Mass. General and Harvard researchers use device to measure how anesthetic affects levels of Alzheimer's-associated proteins.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
A New Tool Brings Personalized Medicine Closer
Scientists from EPFL and ETHZ have developed a powerful tool for exploring and determining the inherent biological differences between individuals, which overcomes a major hurdle for personalized medicine.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
‘Missing Tooth’ Hydrogels Handle Hard-to-Deliver Drugs
Rice University’s custom hydrogel traps water-avoiding molecules for slow delivery.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!